Flutisal Inhalation Capsule 50 mcg + 500 mcg is a combination respiratory therapy containing Salmeterol and Fluticasone Propionate. This dual-action medication is formulated for inhalation and designed for the long-term management of moderate to severe asthma and chronic obstructive pulmonary disease (COPD). By combining a long-acting bronchodilator with a potent inhaled corticosteroid, Flutisal helps improve breathing, reduce inflammation, and prevent exacerbations, offering patients better control over their respiratory conditions.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Flutisal Inhalation Capsule 50 mcg + 500 mcg is indicated for:
Maintenance treatment of moderate to severe asthma in patients who require both a long-acting beta₂-agonist and an inhaled corticosteroid
Long-term management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema
Prevention of asthma-related symptoms such as wheezing, breathlessness, chest tightness, and coughing
This combination therapy is not intended for the relief of acute asthma attacks.
Long-acting Beta₂-Agonist and Inhaled Corticosteroid Combination
Flutisal combines the complementary mechanisms of two active agents:
Salmeterol (50 mcg): A long-acting selective beta₂-adrenergic receptor agonist that relaxes airway smooth muscles, producing bronchodilation. Its prolonged effect helps maintain open airways for up to 12 hours, facilitating easier breathing and symptom control.
Fluticasone Propionate (500 mcg): A potent inhaled corticosteroid that suppresses airway inflammation by inhibiting multiple inflammatory cells and mediators. This reduces airway hyperresponsiveness, edema, and mucus production, improving overall lung function.
Together, these agents provide sustained symptom relief, improved lung function, and reduced frequency of asthma or COPD exacerbations.
Flutisal Inhalation Capsule is intended for inhalation only and should be used with a compatible dry powder inhaler device.
Recommended dose: One capsule inhaled twice daily or as prescribed by a physician
Capsules must not be swallowed
Patients should rinse their mouth with water after inhalation to reduce the risk of oral thrush (candidiasis)
Regular use is essential to achieve optimal therapeutic benefit. Flutisal should not be used as a rescue medication for sudden asthma attacks.
Co-administration with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) may increase systemic exposure to Fluticasone, raising the risk of corticosteroid-related side effects
Use with other long-acting beta₂-agonists should be avoided
Beta-blockers may reduce Salmeterol’s bronchodilatory effect
Concurrent corticosteroid therapy increases the risk of systemic corticosteroid effects
Flutisal is contraindicated in patients with:
Known hypersensitivity to Salmeterol, Fluticasone Propionate, or any capsule components
Acute bronchospasm or status asthmaticus requiring immediate relief
Common side effects include:
Throat irritation or hoarseness
Cough
Oral candidiasis
Headache
Less common but serious side effects may include:
Palpitations, tremor, or hypokalemia
Paradoxical bronchospasm
Signs of adrenal suppression with prolonged use
Use during pregnancy is recommended only if the potential benefit justifies the risk. Caution is advised during breastfeeding, as corticosteroids may be excreted in small amounts in breast milk.
Flutisal is not a rescue inhaler; it does not relieve acute bronchospasm
Long-term therapy requires monitoring for adrenal suppression, osteoporosis, and growth retardation in children
Patients should avoid exposure to alcohol or other CNS depressants that may enhance sedative effects
Regular lung function assessments are recommended to ensure treatment efficacy
Store below 30°C, away from light and moisture. Keep out of the reach of children.
Flutisal works through a dual mechanism: Salmeterol provides prolonged bronchodilation, while Fluticasone Propionate reduces airway inflammation. Together, they improve airflow, decrease airway hyperreactivity, and prevent exacerbations in patients with asthma or COPD.
Login Or Registerto submit your questions to seller
No none asked to seller yet